Lapatinib and lapatinib plus trastuzumab therapy versus trastuzumab therapy for HER2 positive breast cancer patients: an updated systematic review and meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2046-4053
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Lapatinib and lapatinib plus trastuzumab therapy versus trastuzumab therapy for HER2 positive breast cancer patients: an updated systematic review and meta-analysis ; volume:11 ; number:1 ; day:10 ; month:12 ; year:2022 ; pages:1-30 ; date:12.2022
Systematic Reviews ; 11, Heft 1 (10.12.2022), 1-30, 12.2022
- Creator
-
Yuan, Ye
Liu, Xumei
Cai, Yi
Li, Wenyuan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13643-022-02134-9
- URN
-
urn:nbn:de:101:1-2023022021253553677606
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yuan, Ye
- Liu, Xumei
- Cai, Yi
- Li, Wenyuan
- SpringerLink (Online service)
Other Objects (12)
Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer
Trastuzumab-functionalized bionic pyrotinib liposomes for targeted therapy of HER2-positive breast cancer
Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999–2018
An integrated stress response via PKR suppresses HER2+ cancers and improves trastuzumab therapy
Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
Reconfiguring Daoist Cultivation in a Video Game. A Case Study of AMAZING CULTIVATION SIMULATOR
GCNG: graph convolutional networks for inferring gene interaction from spatial transcriptomics data
Genetic mutations in HER2-positive breast cancer: possible association with response to trastuzumab therapy
Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer
Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer
Comparison of Biosimilar Trastuzumab ABP 980 with Reference Trastuzumab in Neoadjuvant Therapy for HER2-positive Breast Cancer – an Analysis of a Large University Breast Cancer Centre
Einsatz von Pertuzumab und Trastuzumab im Vergleich zu Trastuzumab-Monotherapie beim HER2-positiven Mammakarzinom - eine multizentrische Kohortenstudie
Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer
Trastuzumab-functionalized bionic pyrotinib liposomes for targeted therapy of HER2-positive breast cancer
Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999–2018
An integrated stress response via PKR suppresses HER2+ cancers and improves trastuzumab therapy
Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
Reconfiguring Daoist Cultivation in a Video Game. A Case Study of AMAZING CULTIVATION SIMULATOR
GCNG: graph convolutional networks for inferring gene interaction from spatial transcriptomics data
Genetic mutations in HER2-positive breast cancer: possible association with response to trastuzumab therapy
Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer
Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer
Comparison of Biosimilar Trastuzumab ABP 980 with Reference Trastuzumab in Neoadjuvant Therapy for HER2-positive Breast Cancer – an Analysis of a Large University Breast Cancer Centre
Einsatz von Pertuzumab und Trastuzumab im Vergleich zu Trastuzumab-Monotherapie beim HER2-positiven Mammakarzinom - eine multizentrische Kohortenstudie
Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer
Trastuzumab-functionalized bionic pyrotinib liposomes for targeted therapy of HER2-positive breast cancer
Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999–2018
An integrated stress response via PKR suppresses HER2+ cancers and improves trastuzumab therapy
Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
Reconfiguring Daoist Cultivation in a Video Game. A Case Study of AMAZING CULTIVATION SIMULATOR
GCNG: graph convolutional networks for inferring gene interaction from spatial transcriptomics data
Genetic mutations in HER2-positive breast cancer: possible association with response to trastuzumab therapy
Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer
Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer
Comparison of Biosimilar Trastuzumab ABP 980 with Reference Trastuzumab in Neoadjuvant Therapy for HER2-positive Breast Cancer – an Analysis of a Large University Breast Cancer Centre